Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tasidotin in advanced melanoma
NCT00068211Phase 2Completed
- Sponsor
- Sanofi
- Start
- Aug 2003
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tasidotin in melanoma, sponsored by Sanofi. Started Aug 2003; status: completed.
02
Drugs
tasidotin
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00068211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00068211.